Adding Ipilimumab to Nivolumab Doesn’t Provide Meaningful Benefit, Researchers Say
Adding ipilimumab to treatment with nivolumab does not provide a clinically meaningful benefit in patients with certain cancers, a meta-analysis suggests.
Diagnosis & Disease Information
Cancer Patients More Likely to Die From Early Omicron Variants of SARS-CoV-2
Cancer patients were more likely to die from the BA.1 and BA.2 omicron variants of SARS-CoV-2 than from wild-type SARS-CoV-2, data suggest.
Deaths Among Cancer Patients Increased During the First 2 Years of the COVID-19 Pandemic
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
How Transportation Insecurity Impacts Cancer Patients
Cancer patients may be particularly susceptible to transportation-related disruptions in care.
Preventing and Treating Malnutrition in Cancer Patients
Malnutrition may affect 30% to 85% of cancer patients, and it may account for 10% to 20% of deaths in these patients.
Patients Squeezed in Fight Over Who Gets to Bill for Pricey Infusion Drugs
Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients.
- Loading...
Loading...
Next post in News
Loading... 
Loading...